SMOKING HABIT AS A RISK FACTOR ASSOCIATED WITH OCCURRENCE OF LUNG CANCER
Keywords:
lung gancer, epidemiology, death, risk factorsAbstract
Lung cancer is one of the most common causes of mortality in the world, right after cardiovascular diseases.
The motivation for conducting this study was the fact that the number of newly diagnosed and death cases from lung cancer has been constantly growing, especially in the last few years.
The aim of the study was to present lung cancer (LC) as a public health problem today at the global level as well as in the Republic of North Macedonia.
This is an analytical case-control study. It included all patients with a confirmed diagnosis of lung cancer (LC) with histopathological analysis (examined group) and patients who have not had any history of malignancy (control group), in a period of six months. Survey data were collected using a specially designed questionnaire.
The study included a total of 82 respondents in both, the examined and the control group. Regarding the habit of cigarette smoking, the largest percentage of examined respondents (56%) were current smokers, compared to the control group where the largest percentage (56%) were non-smokers. The results obtained showed that the two groups differed significantly with regards to the habit of cigarette smoking.
This study confirmed the association of cigarette smoking habit and lung cancer, where several variables related to smoking were examined (age at which cigarette smoking started, number of cigarettes smoked per day, duration of smoking status, type of cigarettes).
References
Barta JA, Powell CA, Wisnivesky JP. Global Epidemiology of Lung Cancer. Ann Glob Health 2019; 85(1): 8. doi: 10.5334/aogh.2419.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-E386. doi: 10.1002/ijc.29210.
Mao Y, Yang D, He J, Krasna MJ. Epidemiology of Lung Cancer. Surg Oncol Clin N Am 2016; 25(3): 439-445. doi: 10.1016/j.soc.2016.02.001.
World Health Organization. World Cancer Report 2008. Lyon; 2008, http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/wcr_2008.pdf
Jassem E, Szymanowska A, Siemińska A, Jassem J. Palenietytoniu a rakpłuca [Smoking and lung cancer]. PneumonolAlergol Pol 2009; 77(5): 469-473. PMID: 19890827.
Loeb LA, Ernster VL, Warner KE, Abbotts J, Laszlo J. Smoking and lung cancer: an overview. Cancer Res 1984; 44(12 Pt 1): 5940-5958. PMID: 6388830.
Schwartz AG, Cote ML. Epidemiology of Lung Cancer. Adv Exp Med Biol 2016; 893: 21-41. doi: 10.1007/978-3-319-24223-1_2.
Yarto-Jaramillo E. Respiratory system anatomy, physiology, and disease: Guinea pigs and chinchillas. Vet Clin North Am Exot Anim Pract 2011; 14(2): 339-355, vi. doi: 10.1016/j.cvex.2011.03.008.
Arrieta O, Lazcano E. Cáncer de pulmón. El peso de la enfermedad y avances en el diagnóstico y tratamiento. salud publica mex. 2019;61(3):217-218.
Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med 2020; 41(1): 1-24. doi: 10.1016/j.ccm.2019.10.001.
Bilello KS, Murin S, Matthay RA. Epidemiology, etiology, and prevention of lung cancer. Clin Chest Med 2002; 23(1): 1-25. doi: 10.1016/s0272-5231(03)00057-1.
de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am 2012; 50(5): 863-876. doi: 10.1016/j.rcl.2012.06.006.
Sharma R. Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050. Int J Clin Oncol. 2022 Apr;27(4):665-675. doi: 10.1007/s10147-021-02108-2. Epub 2022 Jan 12. PMID: 35020103; PMCID: PMC8753949.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.
Romaszko AM, Doboszyńska A. Multiple primary lung cancer: A literature review. Adv Clin Exp Med 2018; 27(5): 725-730. doi: 10.17219/acem/68631.
Amini A, Verma V, Glaser SM, Shinde A, Sampath S, Stokes WA, et al. Early mortality of stage IV non-small cell lung cancer in the United States. Acta Oncol 2019; 58(8): 1095-1101. doi: 10.1080/0284186X.2019.1599138.
Torre LA, Siegel RL, Jemal A. Lung Cancer Statistics. Adv Exp Med Biol 2016; 893: 1-19. doi: 10.1007/978-3-319-24223-1_1.
Hoffman RM, Sanchez R. Lung Cancer Screening. Med Clin North Am 2017; 101(4): 769-785. doi: 10.1016/j.mcna.2017.03.008.
Schabath MB, Cote ML. Cancer Progress and Priorities: Lung Cancer. Cancer Epidemiol Biomarkers Prev 2019; 28(10): 1563-1579. doi: 10.1158/1055-9965.EPI-19-0221.
Lung cancer statistics | World Cancer Research Fund International (wcrf.org). available from:https://www.statista.com/statistics/1225658/lung-cancer-mortality-in-europe/
Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, et al. Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary. Front Oncol 2019; 9: 1051. doi: 10.3389/fonc.2019.01051.
Bogos K, Kiss Z, Gálffy G, Tamási L, Ostoros G, Müller V, et al. Novel approaches to the epidemiology of lung cancer in Hungary. MagyOnkol 2020; 64(3): 175-181. Hungarian. PMID: 32966347.
Christensen NL, Jekunen A, Heinonen S, Dalton SO, Rasmussen TR. Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison. Acta Oncol 2017; 56(7): 943-948. doi: 10.1080/0284186X.2017.1315172.
Voicu-Măceşeanu A, Nitu M, Olteanu M, Bică D. Epidemiology of lung cancer. Pneumologia 2007; 56(2): 78-84. PMID: 18019752.
Yu Y, Liu H, Zheng S, Ding Z, Chen Z, Jin W, et al. Gender susceptibility for cigarette smoking-attributable lung cancer: a systematic review and meta-analysis. Lung Cancer 2014; 85(3): 351-360. doi: 10.1016/j.lungcan.2014.07.004.
Liao W, Coupland CAC, Burchardt J, Baldwin DR; DART initiative; Gleeson FV, et al. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models. Lancet Respir Med 2023; 11(8): 685-697. doi: 10.1016/S2213-2600(23)00050-4.
Wang X, Ricciuti B, Nguyen T, Li X, Rabin MS, Awad MM, et al. Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer. Cancer Res 2021; 81(9): 2566-2573. doi: 10.1158/0008-5472.CAN-20-3991.
Bergman BP, Mackay DF, Morrison D, Pell JP. Smoking-related cancer in military veterans: retrospective cohort study of 57,000 veterans and 173,000 matched non-veterans. BMC Cancer 2016; 16: 311. doi: 10.1186/s12885-016-2347-5.
Romaszko-Wojtowicz A, Lorenc A, Buciński A, Doboszyńska A. Effects of Tobacco Smoking on the Survivability of Patients with Multiple Cancers and Single Lung Cancer. Int J Environ Res Public Health 2022; 19(15): 9179. doi: 10.3390/ijerph19159179.
Djekic Malbasa J, Kovacevic T, Zaric B, Dugandzija T, Nikolin B, Radovanovic D, et al. Decade of lung cancer in Serbia: tobacco abuse and gender differences. Eur Rev Med Pharmacol Sci 2023; 27(7): 3105-3116. doi: 10.26355/eurrev_202304_31945.
Remen T, Pintos J, Abrahamowicz M, Siemiatycki J. Risk of lung cancer in relation to various metrics of smoking history: a case-control study in Montreal. BMC Cancer 2018; 18(1): 1275. doi: 10.1186/s12885-018-5144-5.
